Patient Derived Xenograft/PDX Models

Patient Derived Xenograft/PDX Models

Global Patient Derived Xenograft/PDX Models Market to Reach $294.7 Million by 2027

Amid the COVID-19 crisis, the global market for Patient Derived Xenograft/PDX Models estimated at US$102.7 Million in the year 2020, is projected to reach a revised size of US$294.7 Million by 2027, growing at aCAGR of 16.3% over the period 2020-2027. Mouse, one of the segments analyzed in the report, is projected to record 15.3% CAGR and reach US$197.3 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Rat segment is readjusted to a revised 18.4% CAGR for the next 7-year period.

The U.S. Market is Estimated at $30.4 Million, While China is Forecast to Grow at 15.7% CAGR

The Patient Derived Xenograft/PDX Models market in the U.S. is estimated at US$30.4 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$51.2 Million by the year 2027 trailing a CAGR of 15.7% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 14.5% and 14% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 11.9% CAGR.We bring years of research experience to this 7th edition of our report. The 164-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others,

  • Champions Oncology, Inc.
  • Charles River Laboratories International, Inc.
  • Crown Bioscience, Inc.
  • Epo Berlin-Buch GmbH
  • Hera BioLabs
  • Oncodesign
  • Pharmatest Services Ltd.
  • The Jackson Laboratory
  • Urolead SAS
  • WuXi AppTec
  • Xentech


Please note: Reports are sold as single-site single-user licenses. The delivery time for hard copies is between 3-5 business days, as each hard copy is custom printed for the organization ordering it. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.


I. INTRODUCTION, METHODOLOGY & REPORT SCOPE
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Global Competitor Market Shares
Patient Derived Xenograft/PDX Models Competitor Market Share Scenario Worldwide (in %): 2019 & 2025
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: Patient Derived Xenograft/PDX Models Global Market Estimates and Forecasts in US$ by Region/Country: 2020-2027
TABLE 2: Patient Derived Xenograft/PDX Models Market Share Shift across Key Geographies Worldwide: 2020 VS 2027
TABLE 3: Mouse (Type) World Market by Region/Country in US$: 2020 to 2027
TABLE 4: Mouse (Type) Market Share Breakdown of Worldwide Sales by Region/Country: 2020 VS 2027
TABLE 5: Rat (Type) Potential Growth Markets Worldwide in US$: 2020 to 2027
TABLE 6: Rat (Type) Market Sales Breakdown by Region/Country in Percentage: 2020 VS 2027
TABLE 7: Pre-Clinical Drug Development (Application) Global Market Estimates & Forecasts in US$ by Region/Country: 2020-2027
TABLE 8: Pre-Clinical Drug Development (Application) Market Share Breakdown by Region/Country: 2020 VS 2027
TABLE 9: Basic Cancer Research (Application) Demand Potential Worldwide in US$ by Region/Country: 2020-2027
TABLE 10: Basic Cancer Research (Application) Share Breakdown Review by Region/Country: 2020 VS 2027
TABLE 11: Pharma & Biotech (End-Use) Worldwide Latent Demand Forecasts in US$ by Region/Country: 2020-2027
TABLE 12: Pharma & Biotech (End-Use) Distribution of Global Sales by Region/Country: 2020 VS 2027
TABLE 13: CRO (End-Use) Sales Estimates and Forecasts in US$ by Region/Country for the Years 2020 through 2027
TABLE 14: CRO (End-Use) Global Market Share Distribution by Region/Country for 2020 and 2027
III. MARKET ANALYSIS
GEOGRAPHIC MARKET ANALYSIS
UNITED STATES
Market Facts & Figures
US Patient Derived Xenograft/PDX Models Market Share (in %) by Company: 2019 & 2025
Market Analytics
TABLE 15: United States Patient Derived Xenograft/PDX Models Market Estimates and Projections in US$ by Type: 2020 to 2027
TABLE 16: United States Patient Derived Xenograft/PDX Models Market Share Breakdown by Type: 2020 VS 2027
TABLE 17: United States Patient Derived Xenograft/PDX Models Latent Demand Forecasts in US$ by Application: 2020 to 2027
TABLE 18: Patient Derived Xenograft/PDX Models Market Share Breakdown in the United States by Application: 2020 VS 2027
TABLE 19: United States Patient Derived Xenograft/PDX Models Latent Demand Forecasts in US$ by End-Use: 2020 to 2027
TABLE 20: Patient Derived Xenograft/PDX Models Market Share Breakdown in the United States by End-Use: 2020 VS 2027
CANADA
TABLE 21: Canadian Patient Derived Xenograft/PDX Models Market Estimates and Forecasts in US$ by Type: 2020 to 2027
TABLE 22: Patient Derived Xenograft/PDX Models Market in Canada: Percentage Share Breakdown of Sales by Type for 2020 and 2027
TABLE 23: Canadian Patient Derived Xenograft/PDX Models Market Quantitative Demand Analysis in US$ by Application: 2020 to 2027
TABLE 24: Canadian Patient Derived Xenograft/PDX Models Market Share Analysis by Application: 2020 VS 2027
TABLE 25: Canadian Patient Derived Xenograft/PDX Models Market Quantitative Demand Analysis in US$ by End-Use: 2020 to 2027
TABLE 26: Canadian Patient Derived Xenograft/PDX Models Market Share Analysis by End-Use: 2020 VS 2027
JAPAN
TABLE 27: Japanese Market for Patient Derived Xenograft/PDX Models: Annual Sales Estimates and Projections in US$ by Type for the Period 2020-2027
TABLE 28: Japanese Patient Derived Xenograft/PDX Models Market Share Analysis by Type: 2020 VS 2027
TABLE 29: Japanese Demand Estimates and Forecasts for Patient Derived Xenograft/PDX Models in US$ by Application: 2020 to 2027
TABLE 30: Patient Derived Xenograft/PDX Models Market Share Shift in Japan by Application: 2020 VS 2027
TABLE 31: Japanese Demand Estimates and Forecasts for Patient Derived Xenograft/PDX Models in US$ by End-Use: 2020 to 2027
TABLE 32: Patient Derived Xenograft/PDX Models Market Share Shift in Japan by End-Use: 2020 VS 2027
CHINA
TABLE 33: Chinese Patient Derived Xenograft/PDX Models Market Growth Prospects in US$ by Type for the Period 2020-2027
TABLE 34: Chinese Patient Derived Xenograft/PDX Models Market by Type: Percentage Breakdown of Sales for 2020 and 2027
TABLE 35: Chinese Demand for Patient Derived Xenograft/PDX Models in US$ by Application: 2020 to 2027
TABLE 36: Chinese Patient Derived Xenograft/PDX Models Market Share Breakdown by Application: 2020 VS 2027
TABLE 37: Chinese Demand for Patient Derived Xenograft/PDX Models in US$ by End-Use: 2020 to 2027
TABLE 38: Chinese Patient Derived Xenograft/PDX Models Market Share Breakdown by End-Use: 2020 VS 2027
EUROPE
Market Facts & Figures
European Patient Derived Xenograft/PDX Models Market: Competitor Market Share Scenario (in %) for 2019 & 2025
Market Analytics
TABLE 39: European Patient Derived Xenograft/PDX Models Market Demand Scenario in US$ by Region/Country: 2018-2025
TABLE 40: European Patient Derived Xenograft/PDX Models Market Share Shift by Region/Country: 2020 VS 2027
TABLE 41: European Patient Derived Xenograft/PDX Models Market Estimates and Forecasts in US$ by Type: 2020-2027
TABLE 42: European Patient Derived Xenograft/PDX Models Market Share Breakdown by Type: 2020 VS 2027
TABLE 43: European Patient Derived Xenograft/PDX Models Addressable Market Opportunity in US$ by Application: 2020-2027
TABLE 44: European Patient Derived Xenograft/PDX Models Market Share Analysis by Application: 2020 VS 2027
TABLE 45: European Patient Derived Xenograft/PDX Models Addressable Market Opportunity in US$ by End-Use: 2020-2027
TABLE 46: European Patient Derived Xenograft/PDX Models Market Share Analysis by End-Use: 2020 VS 2027
FRANCE
TABLE 47: Patient Derived Xenograft/PDX Models Market in France by Type: Estimates and Projections in US$ for the Period 2020-2027
TABLE 48: French Patient Derived Xenograft/PDX Models Market Share Analysis by Type: 2020 VS 2027
TABLE 49: Patient Derived Xenograft/PDX Models Quantitative Demand Analysis in France in US$ by Application: 2020-2027
TABLE 50: French Patient Derived Xenograft/PDX Models Market Share Analysis: A 7-Year Perspective by Application for 2020 and 2027
TABLE 51: Patient Derived Xenograft/PDX Models Quantitative Demand Analysis in France in US$ by End-Use: 2020-2027
TABLE 52: French Patient Derived Xenograft/PDX Models Market Share Analysis: A 7-Year Perspective by End-Use for 2020 and 2027
GERMANY
TABLE 53: Patient Derived Xenograft/PDX Models Market in Germany: Recent Past, Current and Future Analysis in US$ by Type for the Period 2020-2027
TABLE 54: German Patient Derived Xenograft/PDX Models Market Share Breakdown by Type: 2020 VS 2027
TABLE 55: Patient Derived Xenograft/PDX Models Market in Germany: Annual Sales Estimates and Forecasts in US$ by Application for the Period 2020-2027
TABLE 56: Patient Derived Xenograft/PDX Models Market Share Distribution in Germany by Application: 2020 VS 2027
TABLE 57: Patient Derived Xenograft/PDX Models Market in Germany: Annual Sales Estimates and Forecasts in US$ by End-Use for the Period 2020-2027
TABLE 58: Patient Derived Xenograft/PDX Models Market Share Distribution in Germany by End-Use: 2020 VS 2027
ITALY
TABLE 59: Italian Patient Derived Xenograft/PDX Models Market Growth Prospects in US$ by Type for the Period 2020-2027
TABLE 60: Italian Patient Derived Xenograft/PDX Models Market by Type: Percentage Breakdown of Sales for 2020 and 2027
TABLE 61: Italian Demand for Patient Derived Xenograft/PDX Models in US$ by Application: 2020 to 2027
TABLE 62: Italian Patient Derived Xenograft/PDX Models Market Share Breakdown by Application: 2020 VS 2027
TABLE 63: Italian Demand for Patient Derived Xenograft/PDX Models in US$ by End-Use: 2020 to 2027
TABLE 64: Italian Patient Derived Xenograft/PDX Models Market Share Breakdown by End-Use: 2020 VS 2027
UNITED KINGDOM
TABLE 65: United Kingdom Market for Patient Derived Xenograft/PDX Models: Annual Sales Estimates and Projections in US$ by Type for the Period 2020-2027
TABLE 66: United Kingdom Patient Derived Xenograft/PDX Models Market Share Analysis by Type: 2020 VS 2027
TABLE 67: United Kingdom Demand Estimates and Forecasts for Patient Derived Xenograft/PDX Models in US$ by Application: 2020 to 2027
TABLE 68: Patient Derived Xenograft/PDX Models Market Share Shift in the United Kingdom by Application: 2020 VS 2027
TABLE 69: United Kingdom Demand Estimates and Forecasts for Patient Derived Xenograft/PDX Models in US$ by End-Use: 2020 to 2027
TABLE 70: Patient Derived Xenograft/PDX Models Market Share Shift in the United Kingdom by End-Use: 2020 VS 2027
REST OF EUROPE
TABLE 71: Rest of Europe Patient Derived Xenograft/PDX Models Market Estimates and Forecasts in US$ by Type: 2020-2027
TABLE 72: Rest of Europe Patient Derived Xenograft/PDX Models Market Share Breakdown by Type: 2020 VS 2027
TABLE 73: Rest of Europe Patient Derived Xenograft/PDX Models Addressable Market Opportunity in US$ by Application: 2020-2027
TABLE 74: Rest of Europe Patient Derived Xenograft/PDX Models Market Share Analysis by Application: 2020 VS 2027
TABLE 75: Rest of Europe Patient Derived Xenograft/PDX Models Addressable Market Opportunity in US$ by End-Use: 2020-2027
TABLE 76: Rest of Europe Patient Derived Xenograft/PDX Models Market Share Analysis by End-Use: 2020 VS 2027
ASIA-PACIFIC
TABLE 77: Patient Derived Xenograft/PDX Models Market in Asia-Pacific by Type: Estimates and Projections in US$ for the Period 2020-2027
TABLE 78: Asia-Pacific Patient Derived Xenograft/PDX Models Market Share Analysis by Type: 2020 VS 2027
TABLE 79: Patient Derived Xenograft/PDX Models Quantitative Demand Analysis in Asia-Pacific in US$ by Application: 2020-2027
TABLE 80: Asia-Pacific Patient Derived Xenograft/PDX Models Market Share Analysis: A 7-Year Perspective by Application for 2020 and 2027
TABLE 81: Patient Derived Xenograft/PDX Models Quantitative Demand Analysis in Asia-Pacific in US$ by End-Use: 2020-2027
TABLE 82: Asia-Pacific Patient Derived Xenograft/PDX Models Market Share Analysis: A 7-Year Perspective by End-Use for 2020 and 2027
REST OF WORLD
TABLE 83: Rest of World Patient Derived Xenograft/PDX Models Market Estimates and Forecasts in US$ by Type: 2020 to 2027
TABLE 84: Patient Derived Xenograft/PDX Models Market in Rest of World: Percentage Share Breakdown of Sales by Type for 2020 and 2027
TABLE 85: Rest of World Patient Derived Xenograft/PDX Models Market Quantitative Demand Analysis in US$ by Application: 2020 to 2027
TABLE 86: Rest of World Patient Derived Xenograft/PDX Models Market Share Analysis by Application: 2020 VS 2027
TABLE 87: Rest of World Patient Derived Xenograft/PDX Models Market Quantitative Demand Analysis in US$ by End-Use: 2020 to 2027
TABLE 88: Rest of World Patient Derived Xenograft/PDX Models Market Share Analysis by End-Use: 2020 VS 2027
IV. COMPETITION
Total Companies Profiled: 38

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook